Loading...
Uploaded by CHIinnovation on Nov 11, 2009
Gilead Sciences Chairman of the Board & CEO John Martin, Ph.D., discusses HIV treatment innovation and the the potential impact of healthcare reform.
News & Politics
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)